Skip to content
healthcare.dev

PYQUVI

NDC 73289-0089, deflazacort, suspension, from Aucta Pharmaceuticals, Inc..

Product NDC
73289-0089
Status
Listed
Labeler
Aucta Pharmaceuticals, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219417
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0089 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFLAZACORT22.75 mg/mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
73289-0089-17328900890113 mL in 1 BOTTLE (73289-0089-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/39854f19-d8be-6438-e063-6394a90a9422

Use it

Look up 73289-0089 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0089 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73289-0089. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.